Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.160
-0.030 (-2.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Accelerate Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 11.91 | 12.06 | 12.75 | 11.78 | 11.17 | 9.3 | Upgrade
|
| Revenue Growth (YoY) | -0.79% | -5.43% | 8.23% | 5.53% | 20.09% | 63.97% | Upgrade
|
| Cost of Revenue | 9.02 | 9.51 | 9.45 | 12.16 | 6.71 | 4.9 | Upgrade
|
| Gross Profit | 2.89 | 2.55 | 3.3 | -0.38 | 4.46 | 4.4 | Upgrade
|
| Selling, General & Admin | 22.51 | 31.23 | 39.19 | 49.24 | 46.5 | 51.89 | Upgrade
|
| Research & Development | 18.48 | 25.35 | 26.92 | 21.94 | 21.26 | 25.35 | Upgrade
|
| Operating Expenses | 41 | 56.58 | 66.11 | 71.18 | 67.76 | 77.23 | Upgrade
|
| Operating Income | -38.11 | -54.03 | -62.81 | -71.56 | -63.3 | -72.83 | Upgrade
|
| Interest Expense | -10.76 | -7.74 | -3.77 | -15.55 | -15.55 | -14.26 | Upgrade
|
| Interest & Investment Income | 0.7 | 1.12 | 0.55 | 0.09 | 0.86 | 2.81 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.52 | 0.07 | 0.12 | -0.41 | 0.25 | -0.12 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.57 | 0.11 | -0.23 | -0.02 | -0.06 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -48.22 | -60.47 | -66.14 | -87.45 | -77.8 | -84.42 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.4 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.42 | 12.96 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.74 | -13.25 | 3.57 | 9.79 | - | - | Upgrade
|
| Pretax Income | -52.89 | -60.77 | -62.57 | -77.66 | -78.2 | -84.42 | Upgrade
|
| Income Tax Expense | 0.56 | 0.85 | -0.08 | 0.05 | 0.01 | -0.11 | Upgrade
|
| Net Income | -53.45 | -61.62 | -62.49 | -77.7 | -78.21 | -84.31 | Upgrade
|
| Net Income to Common | -53.45 | -61.62 | -62.49 | -77.7 | -78.21 | -84.31 | Upgrade
|
| Shares Outstanding (Basic) | 21 | 12 | 8 | 6 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 12 | 8 | 6 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | 83.18% | 51.86% | 33.10% | 10.21% | 2.76% | 0.02% | Upgrade
|
| EPS (Basic) | -2.59 | -4.94 | -7.61 | -12.59 | -13.96 | -15.47 | Upgrade
|
| EPS (Diluted) | -2.59 | -4.94 | -7.61 | -12.59 | -14.00 | -15.47 | Upgrade
|
| Free Cash Flow | -27.5 | -41.23 | -49.28 | -47.93 | -51.76 | -65.12 | Upgrade
|
| Free Cash Flow Per Share | -1.33 | -3.30 | -6.00 | -7.76 | -9.24 | -11.95 | Upgrade
|
| Gross Margin | 24.25% | 21.15% | 25.90% | -3.23% | 39.94% | 47.33% | Upgrade
|
| Operating Margin | -319.99% | -448.03% | -492.51% | -607.37% | -566.95% | -783.38% | Upgrade
|
| Profit Margin | -448.85% | -510.97% | -490.06% | -659.50% | -700.47% | -906.80% | Upgrade
|
| Free Cash Flow Margin | -230.92% | -341.91% | -386.46% | -406.77% | -463.56% | -700.48% | Upgrade
|
| EBITDA | -34.68 | -50.77 | -59.81 | -69.04 | -60.3 | -70.23 | Upgrade
|
| D&A For EBITDA | 3.43 | 3.25 | 3 | 2.52 | 3 | 2.6 | Upgrade
|
| EBIT | -38.11 | -54.03 | -62.81 | -71.56 | -63.3 | -72.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.